13
Apr
2021
17:00
BST
17:00
CET
Webinar
Clinical and economic impact of remote heart failure diagnostics in device patients
-
Views:
5644
-
Likes:
18
Overview
Learn how HeartLogic™, a remote heart failure diagnostics tool for device patients, may support lowering heart-failure related hospitalizations and pro-actively treating heart failure patients.
CRM-983803-AA
Faculty:
Professor Roy Gardner
Dr Ward Heggermont
This webinar is supported by
Agenda
Learning Objectives
- Learn how lowering heart-failure related hospitalizations is not only of utmost importance to patients but also to healthcare providers and payers, including governments and insurance companies.
- Discover how to integrate remote diagnostics for heart failure in device patients in your clinical practice.
- Get educated on pro-active treatment of heart failure using Boston Scientific’s HeartLogic™ algorithm, which triggers alerts about a month before decompensation will occur.
- Learn about the economic value of remote heart failure diagnostics that prevent heart failure hospitalizations.
- Discover the clinical benefit of avoiding heart failure hospitalizations.
Audience
- Electrophysiologists
- Referring Physicians
- Heart Failure Specialists
Faculty Biographies
Professor Roy Gardner
Consultant Cardiologist at the Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow (United Kingdom)
Professor Gardner is a Consultant Cardiologist with a special interest in advanced heart failure, complex devices, cardiac transplantation, and mechanical circulatory support at the Scottish National Advanced Heart Failure Service. Roy Gardner is an Honorary Professor, Institute of Cardiovascular & Medical Sciences, University of Glasgow as well as Chair Elect of the British Society for Heart Failure (BSH)
Dr Ward Heggermont
Ward Heggermont obtained his Medical Degree in 2009 at the Catholic University of Leuven (Belgium).
He worked as a student-researcher in the Rega Institute (Leuven, Belgium), between 2004 and 2007, under the guidance of Prof. Dr. Erik De Clercq and Prof. Dr. Johan Neyts. He has a particular interest in the overlapping scientific fields of Virology and Cardiology, and Metabolism.
He currently works at the Academic Hospital of Aalst and he will continue his research at the centre in Maastricht, and at the Hospital of Aalst, Belgium where he is co-Director of the Cardiovascular Center.